Adjuvant trastuzumab deruxtecan (T-DXd; Enhertu) significantly improved invasive disease-free survival compared with ...

By a News Reporter-Staff News Editor at Insurance Daily News-- New research on Managed Care is the subject of a report. According to news reporting originating in Aurora, United States, by NewsRx ...

Ryan Haumschild, PharmD, MS, MBA: With this new agent being FDA-approved and one coming this summer, I think there’s a lot of excitement, at least, amongst us, because I think we recognize the benefit ...

Please provide your email address to receive an email when new articles are posted on . Improving diversity in cancer clinical trial enrollment has become an increased priority among oncology ...

Actionability of Synthetic Data in a Heterogeneous and Rare Health Care Demographic: Adolescents and Young Adults With Cancer Extracting inclusion and exclusion criteria in a structured, automated ...

Patients with PsA have a higher prevalence of MetS compared with members of the general population and individuals with other inflammatory arthropathies.

Please provide your email address to receive an email when new articles are posted on . NEWPORT BEACH, Calif. — Patient factors that can impact outcomes after same-day total joint reconstruction ...

Individuals with MetALD vs MASLD have significantly higher risks for liver-related events, liver cancer, and extrahepatic cancers.